Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Cyclenium Pharma and Southern Research Institute Announce Drug Discovery and Development Collaboration
XBiotech Announces Phase I/II Study Results in Lancet Oncology
Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU
VentiRx Pharmaceuticals Announces the Completion of Patient Enrollment in Randomized, Placebo-controlled Phase 2 Trial of VTX-2337 in Combination with Pegylated-Liposomal Doxorubicin in Platinum-resistant Ovarian Cancer
Neurosurgery journal published study reinforces value of high-field iMRI English
Nora Therapeutics Announces $18 Million Series B Financing
Space institute funds eye tracking technology and software-enabled therapeutics for brain health
Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice
Sanguine to begin work with Mayo Clinic Bioservices English
Duquesne Research, Supported with $1.4 Million NIH Grant, Could Lead to Earlier Cancer Detection
ePharmaSolutions' ReferralPlus™ Increases Match Rate For Clinical Trial Volunteers By More than 66% During Pilot Studies With Major Pharmaceutical Consortium Members
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego
Osteoarthritis Study shows ActiPatch® Therapy Significantly Relieves Knee Pain
Phase 2a Clinical Study Data of AJM300, Oral alpha 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014
Esteemed Cell Biologist Selected to Receive America's Most Distinguished Prize in Medicine
inVentiv Health Clinical Engaged by IntelliCell Biosciences, a Regenerative Medicine Company, as Clinical Research Organization for Osteoarthritis IND
First CERAMENT™|G Study With Local Gentamicin Elution Shows Safe Bone Healing With Effective New Bone Ingrowth In Osteomyelitis Patients Spanish Spanish
Clinical Trial Investigates Cord Blood Stem Cells to Treat Cerebral Palsy in Children
Dermatology Development Experts bioskin Continues U.S. Expansion, Launches New Website
Positive Results Of MuGard Study In Erosive Oral Lichen Planus Presented At International Oral Medicine Meeting
AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer
Beyond the Hype of Global Next-Generation Sequencing Informatics: Inflated Expectations in an Emerging Market
Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava™ Blood Tests For Breast Cancer Detection
Interim Results of AirXpanders' Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders
Clinical Trial to Test Modified Citrus Pectin in Prostate Cancer
Center for Bedwetting Treatment improves lives for millions of teenagers worldwide
TransMedics® Announced Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management
Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease
The Scripps Research Institute Announces 'Scripps Advance,' a New Drug Discovery Initiative
Oncolytics Biotech Inc. Collaborators Present Preclinical Research on Liver Cancer at UK Oncolytic Virus Conference
Oncolytics Biotech Inc. Collaborators Present Head and Neck Cancer Biomarker Preclinical Research at UK Oncolytic Virus Conference
ROX Medical completes enrollment in CONTROL-HTN trial Spanish
Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress
LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL)
AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™
New therapy for advanced prostate cancer available in Trinidad & Tobago
Laboratory-Grown Vaginas Implanted in Patients, Scientists Report
EPA Experiments Seek to Harm Sick Patients, States Association of American Physicians and Surgeons
Columbia Asia Hospitals, a Global Healthcare Provider to Conduct Surgical Workshop to Train Doctors on "Fistula Procedures on Dialysis Patients"
GenomeDx Biosciences Announces Data on Genomic Tests for Prostate and Bladder Cancer to be Presented at EAU Annual Meeting
Closure of Testing Lab Triggers Calls for Support
Oncolytics Biotech Inc. Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference
Clinical Trial Management System Market is expected to reach USD 1,848.5 million in 2019: Transparency Market Research
AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress™
New Data Show How Hepatic Encephalopathy Contributes to Burden of Liver Disease
Providence Saint Joseph Medical Center Announces First Patient in U.S. to Receive MRI Scan in Clinical Study of MRI-Compatible Pacemaker

< Prev Next >
PR Newswire - United Business Media